Results 31 to 40 of about 395,313 (278)
Journal of Clinical Medicine, 2022 Mycoplasma pneumoniae is a major causative pathogen of community-acquired pneumonia in children, and the treatment of choice is macrolides. There is an increasing trend in reports of refractory clinical responses despite macrolide treatment due to the ...
Yunjung Choi +28 more
semanticscholar +1 more source
High Prevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in Children with Acute Respiratory Infections from Lima, Peru. [PDF]
PLoS ONE, 2017 Mycoplasma pneumoniae and Chlamydia pneumoniae are atypical pathogens responsible for pneumonia and a leading cause of morbidity and mortality in low income countries.
Juana Del Valle-Mendoza +10 more
doaj +1 more source
Risk Factors for Severe Mycoplasma Pneumoniae Pneumonia in Children: a Meta-analysis [PDF]
Zhongguo quanke yixueBackground In recent years, the incidence of Mycoplasma pneumoniae pneumonia in children has continued to rise, with a corresponding increase in the number of severe Mycoplasma pneumoniae pneumonia, attracting widespread attention from clinical ...
YANG Shuo, LIU Xinying, WANG Huizhe, LI Huanmin, LI Xinmin
doaj +1 more source
The timing of azithromycin treatment is not associated with the clinical prognosis of childhood Mycoplasma pneumoniae pneumonia in high macrolide-resistant prevalence settings. [PDF]
PLoS ONE, 2018 Mycoplasma pneumoniae infection is a major cause of community-acquired pneumonia in children. We performed a retrospective study to evaluate the clinical impact of the timing of azithromycin treatment in children with Mycoplasma pneumoniae pneumonia in ...
Dehua Yang, Linghong Chen, Zhimin Chen
doaj +1 more source
Development of a Nomogram for Predicting Refractory Mycoplasma pneumoniae Pneumonia in Children
Frontiers in Pediatrics, 2022 Background In children, refractory Mycoplasma pneumoniae pneumonia (RMPP) may result in severe complications and high medical costs. There is research on a simple and easy-to-use nomogram for early prediction and timely treatment of RMPP.
Fangfang Shen +6 more
semanticscholar +1 more source
Comparative characteristics of typical and atypical (Mycoplasma) pneumonia in children
Детские инфекции (Москва), 2021 Aim: To compare the features of clinical-anamnestic and laboratory-instrumental data and treatment of children with typical and atypical (Mycoplasma) forms of pneumonia.Materials and methods.
T. A. Britkova +2 more
doaj +1 more source
European Journal of Case Reports in Internal Medicine, 2019 Introduction: Mycoplasma pneumonia is one of the most common types of pneumonia, although it is often not diagnosed due to mild clinical course. Aims: In this case study we aim to describe the importance of considering mycoplasma pneumonia in high-risk
A. Graham Cummiskey, Michael Reardon
doaj +1 more source
Fulminant Mycoplasma pneumoniae Pneumonia.
Internal Medicine, 2001 A 64-year-old woman, who was previously in good health was admitted because of progressive respiratory distress. Her chest radiograph revealed bilateral widespread alveolar infiltrates. She was given a diagnosis of pneumonia caused by Mycoplasma pneumoniae serologically, acute respiratory distress syndrome, and disseminated intravascular coagulation ...
Y, Takiguchi +5 more
openaire +3 more sources
Case Reports in Medicine, 2018 Mycoplasma pneumoniae is a common cause of community-acquired pneumonia, and many extrapulmonary manifestations have been described, but rhabdomyolysis is infrequently reported in adults.
Jaspreet Kaler +6 more
doaj +1 more source
Mycoplasma pneumoniae and Adenovirus Coinfection Cause Pediatric Severe Community-Acquired Pneumonia
Microbiology spectrum, 2022 Pathogens that cause pediatric severe community-acquired pneumonia (SCAP) requiring bronchoscopy intervention are understudied. Through this study, we explore the etiology of SCAP form alveolar lavage fluid (ALF) samples by the RespiFinder 2SMART multi ...
Fei Li +11 more
semanticscholar +1 more source